Carboplatin

Subsidy Information and Financing Scheme

SDL

MSHL

Drug Guidance

Post-marketing information

Yes

Summary of Biologics

Active ingredient: Carboplatin

General information

Subsidy Information and Financing Scheme

[SDL] Carboplatin Injection 150 mg/15 mL, 450 mg/45 mL

[MSHL] Carboplatin Vial 150 mg/15 mL, 450 mg/45 mL

For cancer treatment.

Legend

This section shows the following:

Subsidy Scheme and Clinical Indication (where applicable) of drugs listed in the MOH List of Subsidised Drugs
Subsidised brands of vaccines recommended in the National Immunisation Schedules listed in the MOH Subsidised Vaccine List
Cancer Drug and Clinical Indication listed in the MediShield Life Cancer Drug List

As this website is updated monthly, please refer to MOH List of Subsidised Drugs, MOH Subsidised Vaccine List or MediShield Life Cancer Drug List for the most updated information.

Legend list

Indicator	Legend
SDL	Standard Drug List
MAF	Medical Assistance Fund
SVL	Subsidised Vaccine List
MSHL	Cancer Drug and Clinical Indication listed in the MediShield Life Cancer Drug List

Drug Guidance for Subsidy

Not Applicable

General Availability in Public Healthcare Institution

Note:

General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.

Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Drug availability

Formulation	Public Healthcare Institution
Injection 150 mg/15 mL	Khoo Teck Puat Hospital Ng Teng Fong General Hospital National University Hospital Tan Tock Seng Hospital
Injection 450 mg/45 mL	KK Women's and Children's Hospital National Cancer Centre Ng Teng Fong General Hospital National University Hospital Singapore General Hospital Tan Tock Seng Hospital

Registered Product(s) Information

Clinical and product info

Clinical info	Product Info
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch. The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice.	Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information.

Clinical info

Product Info

Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch.

The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice.

Information available here are product details as registered with the HSA. As this website is updated

monthly, please refer to HSA Infosearch for the most updated product information.

Intravenous

* The following products do not have any clinical information available